Authors


Michael J. Shumski, MD, MSE

Latest:

Is office-based surgery a harbinger of things to come for ophthalmology?

One practice’s experience with office-based surgery validates peer-reviewed study.


Greg Pierce

Latest:

Creating a positive patient financial journey for refractive error procedures

Clear communication, transparent priceing, options are key to positive experience


Ramin Tadayoni, MD, PhD

Latest:

Quest continues for topical treatments for posterior segment

Novel treatments are now shifting paradigm in care of retinal diseases.


Bela Parekh

Latest:

Balancing Motherhood and Medicine: Navigating Maternity in Ophthalmology

Balancing motherhood & ophthalmology: Prioritize family planning, set boundaries, integrate work & personal life. Insights from ophthalmologist-moms.


Aleksandra Rachitskaya, MD

Latest:

Rare Disease Day: What it means for the future of inherited retinal diseases

Aleksandra Rachitskaya, MD, discusses how the treatment landscape for inherited retinal diseases has changed and her hope for the future.


Marc D. de Smet, MD, PhD

Latest:

Managing neovascular retinal disease in COVID-19 era requires careful approach

Minimizing clinic visits, maximizing use of imaging modalities are key.


Jennifer K. Dunnigan

Latest:

Unlocking health mysteries

Researchers find a strong link between Alzheimer's disease and retinal thinning


Shlomo Melamed, MD

Latest:

Lessons from the Togo Glaucoma Project

SLT shows promise as treatment for millions of Africans with glaucoma.


Katherine Talcott, MD

Latest:

A Case of a Geographic Atrophy Patient Needing Low Vision Rehabilitation

An ophthalmologist presents the case of a 76-year-old woman who has geographic atrophy and progressively worsening vision in her right eye, with a history of macular macrovessel and choroidal hemangioma.



Fotis Topouzis, MD, PhD

Latest:

Unraveling the genetics of glaucoma

Details enhance knowledge of biological pathways that contribute to disease pathogenesis.


Michael Savetsky, MD

Latest:

Real-world outcomes validate intraocular drug delivery method

Ophthalmologists seek methods to control postoperative inflammation.


Chirag Jhaveri, MD

Latest:

Clinical Implications of Port Delivery System in Retinal Diseases

Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.


Grace Koennecke

Latest:

AAO 2024: Ocular imaging in the emergency department can provide timely, accurate diagnosis

Valerie Biousse, MD, from the Emory University in Atlanta, Georgia, shared insights on how ocular imaging in the emergency department can provide timely, accurate diagnosis while also benefiting the on-call ophthalmologists. She shared these thoughts at this year's AAO meeting held in Chicago, Illinois.


Gaynor Fries

Latest:

Celebrating women in leadership

In ophthalmology, women continue to take on leadership roles and make a difference in the profession.


SPONSORED BY BAUSCH + LOMB

Latest:

A Cataract Case Study with Dr. Rahul Pandit

Using an NSAID to Manage Inflammation and Pain After Cataract Surgery


John H. Merey, MD

Latest:

Ophthalmologist Holocaust survivor shares his story

In observance of International Holocaust Remembrance Day this January 27, John H. Merey, MD, may be the only Holocaust survivor still in the practice of ophthalmology.


Judy Kim, MD

Latest:

Promoting Treatment Adherence in nAMD and DME

Experts discuss the use of steroids, particularly in the context of diabetic macular edema (DME). The inflammatory nature of DME reveals the effectiveness of steroids, especially in cases where persistent fluid remains despite anti-VEGF treatment.


Ashlie Leal

Latest:

Virtual reality brings care to at-need areas

Technology offers accessibility, scalability to countries where care is needed the most.


Haoxing Douglas Jin, MD

Latest:

Ocular manifestations of mycoplasma-induced rash and mucositis

Aggressive lubrication combined with topical steroids, antibiotics boosts chances of recovery.


Sara Giammaria, MD

Latest:

Pivotal study data drive glaucoma patient treatment decisions

Two trials examine factors affecting the risk of disease.


Ferdinand K. Hui, MD

Latest:

Clearing hurdles to large scale telemedicine adoption

During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye



Vanita Berry, PhD

Latest:

Focus on molecular mechanisms underlying cataract development

Several hundred genes are associated with congenital forms.


Boris Malyugin, MD, PhD

Latest:

Cataract surgery pearls for cases with poor mydriasis, zonules

Factors that lead to complications must be managed for best outcomes.


Dimitrios Giannoulis, MD

Latest:

Unraveling the genetics of glaucoma

Details enhance knowledge of biological pathways that contribute to disease pathogenesis.


Beeran Meghpara, MD

Latest:

Cyropreserved amniotic membrane option for management of DED, NK

Treatment requires a systematic, multifaceted approach to improve outcomes.


John Doane, MD, FACS

Latest:

Advances in Technology for SMILE procedure

John Doane, MD, discusses latest advancements in laser technology that enhance the surgical experience, speed, and precision of the SMILE procedure.


Austin F. Cheng, Esq

Latest:

Payment points: The ASC perspective

Transparent pricing in elective surgeries is crucial.


Errica Spoiala, MD

Latest:

Study examines efficiency of physiotherapy in treating, preventing uncomplicated acquired myopia

Research explores innovative physiotherapeutic approaches to managing myopia progression, showing promising results in slowing its advancement over two years.

© 2024 MJH Life Sciences

All rights reserved.